HomeAI · summaries
Storia in 11 fonti
QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax - Moderna (NASDAQ:MRNA)
FDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligibility for adults 65+ and those with high-risk conditions.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
- ·
benzinga.com
QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax - Moderna (NASDAQ:MRNA)
FDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligibility for adults 65+ and those with high-risk conditions.
